- Home
- BMEA vs TOYO Comparison
BMEA vs TOYO Comparison
Compare BMEA & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- TOYO
- Stock Information
- Founded
- BMEA 2017
- TOYO 2022
- Country
- BMEA United States
- TOYO Japan
- Employees
- BMEA N/A
- TOYO N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- TOYO
- Sector
- BMEA Health Care
- TOYO
- Exchange
- BMEA Nasdaq
- TOYO NYSE
- Market Cap
- BMEA 145.0M
- TOYO 161.2M
- IPO Year
- BMEA 2021
- TOYO N/A
- Fundamental
- Price
- BMEA $4.25
- TOYO $3.74
- Analyst Decision
- BMEA Buy
- TOYO
- Analyst Count
- BMEA 13
- TOYO 0
- Target Price
- BMEA $27.92
- TOYO N/A
- AVG Volume (30 Days)
- BMEA 831.0K
- TOYO 75.1K
- Earning Date
- BMEA 10-29-2024
- TOYO 02-21-2025
- Dividend Yield
- BMEA N/A
- TOYO N/A
- EPS Growth
- BMEA N/A
- TOYO N/A
- EPS
- BMEA N/A
- TOYO 0.76
- Revenue
- BMEA N/A
- TOYO $200,455,385.00
- Revenue This Year
- BMEA N/A
- TOYO N/A
- Revenue Next Year
- BMEA N/A
- TOYO N/A
- P/E Ratio
- BMEA N/A
- TOYO $4.89
- Revenue Growth
- BMEA N/A
- TOYO N/A
- 52 Week Low
- BMEA $3.61
- TOYO $1.36
- 52 Week High
- BMEA $20.21
- TOYO $15.61
- Technical
- Relative Strength Index (RSI)
- BMEA 42.32
- TOYO N/A
- Support Level
- BMEA $3.78
- TOYO N/A
- Resistance Level
- BMEA $4.29
- TOYO N/A
- Average True Range (ATR)
- BMEA 0.30
- TOYO 0.00
- MACD
- BMEA 0.15
- TOYO 0.00
- Stochastic Oscillator
- BMEA 89.71
- TOYO 0.00
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About TOYO TOYO CO LTD
Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.